Targeting myelomonocytic cells to revert inflammation-dependent cancer promotion.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 16230363.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Tumor development and progression are strongly linked to inflammation and the presence of tumor-associated macrophages (TAMs). In murine tumors, antitumor activity can be achieved by targeting TAM recruitment, survival, activation, polarization, effector signaling, or extracellular matrix interactions. Thus, it may be possible to increase the efficacy of conventional cancer therapeutic strategies by targeting TAMs.
Medical subject headings
- Inflammation
- Macrophages
- Neoplasms